Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

Abstract

Treatment of MDR tuberculosis involves substantial risk of acquired resistance to SLDs, increasing as baseline drug resistance increases. The risk was significantly lower in programs documented by the GLC to meet specific standards.